Hydrea and Ambien drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydrea (hydroxyurea) and Ambien (zolpidem tartrate). Common drug interactions include dyspnoea exertional among females and platelet count increased among males.

The phase IV clinical study analyzes what interactions people have when they take Hydrea and Ambien. It is created by eHealthMe based on reports of 94 people who take the same drugs from the FDA, and is updated regularly.

What is Hydrea?

Hydrea has active ingredients of hydroxyurea. It is often used in polycythemia vera. eHealthMe is studying from 9,083 Hydrea users. Check the latest studies of Hydrea.

What is Ambien?

Ambien has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 93,519 Ambien users. Check the latest studies of Ambien.



On Jul, 15, 2026

94 people who take Hydrea and Ambien together, and have interactions are studied.

Hydrea and Ambien drug interactions.

What are the common drug interactions of Hydrea and Ambien, by gender? *:

female:

  1. Dyspnoea exertional (breathlessness or shortness of breath)
  2. Non-cardiac chest pain
  3. Splenic rupture
  4. Abdominal distension
  5. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  6. Acute respiratory distress syndrome
  7. Allergy to chemicals
  8. Aseptic necrosis bone
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Blood creatinine increased

male:

  1. Platelet count increased
  2. Death
  3. Anaemia (lack of blood)
  4. Aspartate aminotransferase increased
  5. Blood bilirubin increased
  6. Blood creatinine increased
  7. Blood glucose increased
  8. Blood urea increased
  9. Chronic kidney disease
  10. Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Hydrea and Ambien, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Pain
  2. Dyspnoea exertional (breathlessness or shortness of breath)
  3. Non-cardiac chest pain
  4. Cellulitis (infection under the skin)
  5. Death
  6. Haematocrit decreased
  7. Haemoglobin decreased
  8. Nausea (feeling of having an urge to vomit)
  9. Rash
  10. Red blood cell count decreased

30-39:

  1. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  2. Pneumonia
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Diabetes mellitus inadequate control
  6. Enterococcal infection
  7. Neoplasm progression (growth of tumour)
  8. Oedema peripheral (superficial swelling)
  9. Pain in extremity
  10. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

40-49:

  1. Hip arthroplasty
  2. Injection site pain
  3. Osteonecrosis (death of bone)

50-59:

  1. Stomatitis (inflammation of mucous membrane of mouth)
  2. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  3. Arthralgia (joint pain)
  4. Back pain
  5. Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
  6. Chest pain
  7. Clostridial infection (infectious conditions by clostridium bacteria)
  8. Colitis (inflammation of colon)
  9. Contusion (a type of hematoma of tissue in which capillaries)
  10. Dehydration (dryness resulting from the removal of water)

60+:

  1. Fatigue (feeling of tiredness)
  2. Haemoglobin decreased
  3. Dry skin
  4. Fall
  5. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  6. Rash
  7. Back pain
  8. Blood potassium increased
  9. Chest injury
  10. Diarrhoea

What are the existing conditions these people have? *

  1. Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 16 people, 17.02%
  2. Primary Myelofibrosis (primary disorder of the bone marrow): 15 people, 15.96%
  3. Stress And Anxiety: 13 people, 13.83%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 12.77%
  5. Depression: 12 people, 12.77%
  6. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 12 people, 12.77%
  7. Pain: 9 people, 9.57%
  8. High Blood Pressure: 8 people, 8.51%
  9. Nausea (feeling of having an urge to vomit): 7 people, 7.45%
  10. Essential Thrombocythaemia (chronic blood cancer): 7 people, 7.45%

* Approximation only. Some reports may have incomplete information.

Do you take Hydrea and Ambien?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hydrea and Ambien:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hydrea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ambien:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydrea and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ambien and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on hydroxyurea and zolpidem tartrate (the active ingredients of Hydrea and Ambien, respectively), and Hydrea and Ambien (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: